New compounds

Details for Australian Patent Application No. 2009275964 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Treu, Matthias; Karner, Thomas; Reiser, Ulrich

Agent Spruson & Ferguson

Pub. Number AU-A-2009275964

PCT Pub. Number WO2010/012747

Priority 08161381.2 29.07.08 EP

Filing date 28 July 2009

Wipo publication date 4 February 2010

International Classifications

C07D 403/00 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 209/34 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

3 February 2011 PCT application entered the National Phase

  PCT publication WO2010/012747 Priority application(s): WO2010/012747

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009275966-Immunotherapy compositions for the treatment and prevention of amyloidosis

2009275963-Process of isolating enantiomer components from enantiomer mixtures by particle-size-controlled crystallization